BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodríguez B, Nani JV, Almeida PGC, Brietzke E, Lee RS, Hayashi MAF. Neuropeptides and oligopeptidases in schizophrenia. Neurosci Biobehav Rev 2020;108:679-93. [PMID: 31794779 DOI: 10.1016/j.neubiorev.2019.11.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang Q, Li Y, Li B, Gong Y. A novel multi-class classification model for schizophrenia, bipolar disorder and healthy controls using comprehensive transcriptomic data. Comput Biol Med 2022;148:105956. [PMID: 35981456 DOI: 10.1016/j.compbiomed.2022.105956] [Reference Citation Analysis]
2 Fritze S, Brandt GA, Kubera KM, Schmitgen MM, Northoff G, Geiger-Primo LS, Tost H, Meyer-Lindenberg A, Wolf RC, Hirjak D. Structural alterations of amygdala and hypothalamus contribute to catatonia. Schizophr Res 2022:S0920-9964(22)00165-7. [PMID: 35597738 DOI: 10.1016/j.schres.2022.05.003] [Reference Citation Analysis]
3 Patel S, Sharma D, Uniyal A, Akhilesh, Gadepalli A, Tiwari V. Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside. Metab Brain Dis 2022. [PMID: 35239143 DOI: 10.1007/s11011-022-00926-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nani JV, Almeida PGC, Noto C, Bressan RA, Brietzke E, Hayashi MAF. Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia. Nordic Journal of Psychiatry. [DOI: 10.1080/08039488.2021.2023217] [Reference Citation Analysis]
5 Cid-Jofré V, Moreno M, Reyes-Parada M, Renard GM. Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists. Int J Mol Sci 2021;22:12077. [PMID: 34769501 DOI: 10.3390/ijms222112077] [Reference Citation Analysis]
6 Almulla AF, Moustafa SR, Al-Dujaili AH, Al-Hakeim HK, Maes M. Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments. Braz J Psychiatry 2021;43:131-7. [PMID: 32556004 DOI: 10.1590/1516-4446-2020-0908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Campeiro JD, Nani JV, Monte GG, Almeida PGC, Mori MA, Hayashi MAF. Regulation of monoamine levels by typical and atypical antipsychotics in Caenorhabditis elegans mutant for nuclear distribution element genes. Neurochem Int 2021;147:105047. [PMID: 33872680 DOI: 10.1016/j.neuint.2021.105047] [Reference Citation Analysis]
8 Correia BSB, Nani JV, Waladares Ricardo R, Stanisic D, Costa TBBC, Hayashi MAF, Tasic L. Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia. Biomedicines 2021;9:235. [PMID: 33652776 DOI: 10.3390/biomedicines9030235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mizuki Y, Sakamoto S, Okahisa Y, Yada Y, Hashimoto N, Takaki M, Yamada N. Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus. Int J Neuropsychopharmacol 2021;24:367-82. [PMID: 33315097 DOI: 10.1093/ijnp/pyaa097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nani JV, Lee RS, Yonamine CM, Sant'Anna OA, Juliano MA, Gadelha A, Mari JJ, Hayashi MAF. Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics. Sci Rep 2020;10:18513. [PMID: 33116174 DOI: 10.1038/s41598-020-75616-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Madireddy S, Madireddy S. Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia. Brain Sci. 2020;10. [PMID: 33081261 DOI: 10.3390/brainsci10100742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
12 Nani JV, Dal Mas C, Yonamine CM, Ota VK, Noto C, Belangero SI, Mari JJ, Bressan R, Cordeiro Q, Gadelha A, Hayashi MAF. A study in first-episode psychosis patients: does angiotensin I-converting enzyme (ACE) activity associated with genotype predict symptoms severity reductions after treatment with the atypical antipsychotic risperidone? Int J Neuropsychopharmacol 2020:pyaa050. [PMID: 32696960 DOI: 10.1093/ijnp/pyaa050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]